The role of KRAS-p.G13D-mutation in metastatic colorectal cancer for patients receiving first-line therapy with FOLFIRI and bevacizumab

D. P. Modest, S. Stintzing, A. Jung, J. Neumann,Fischer L. von Weikersthal, U. Vehling-Kaiser, C. Giessen,C. Schulz, T. Kirchner, V. Heinemann,D. Modest

ONKOLOGIE（2011）

Cited 0|Views1

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined